This blog discusses how OB/GYNs need not only to understand the science behind genetic screening but also to counsel patients properly about the results.
Prenatal Genetic Testing
Cell-free fetal DNA screening tests for trisomy 21 are more accurate than standard screening with nuchal translucency even in low-risk women.
SMFM 2015: A failed result on noninvasive prenatal testing (NIPT) may provide insight into what subsequent tests may find, research reveals.
These 5 predictions by Adam Wolfberg, MD, provide insight into how genetic testing—NIPT to microarray and cost to quality—continues to evolve.
Amniocentesis, CVS, noninvasive prenatal testing, microarray . . . the rapid advancements in prenatal genetic testing can be dizzying. These 7 expert tips can help navigate the gamut.
New research may have found a way to better predict whether women with threatened preterm labor are in true labor or false labor.
New research expected this year will bring about significant changes to clinical practice. Here, society leaders share what’s on their radar for 2014.
What research from the past year will have the most significant impact on women's health care? The leaders of five major ob/gyn societies weigh in.
New research presented at The Pregnancy Meeting™ last week in New Orleans shows that noninvasive prenatal testing can detect more than 80% of chromosomal abnormalities.
The ethical issues between two new technologies are stark. One aims to cure disease, whereas the other threatens to alter fundamentally the parent-child relationship.